May 1, 2026 · Adalimumab-adaz injection is also used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given …

HYRIMOZ adalimumab-adaz is an adalimumab biosimilar for inflammatory conditions. Learn about indications, support resources, and treatment guidance for patients.

Dec 21, 2022 · Hyrimoz (adalimumab or adalimumab-adaz) is an injection used to treat many different autoimmune conditions (e.g., different types of arthritis, Crohn's disease (CD), ulcerative colitis (UC), …

Nov 18, 2025 · Get clear safety guidance for Adalimumab-adaz, including warnings, precautions, when to seek medical assistance, and how to use it correctly.

Nov 20, 2025 · Adalimumab-adaz package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

What is HYRIMOZ® (adalimumab-adaz)? HYRIMOZ is a prescription medicine called a tumor necrosis factor (TNF) blocker used: To reduce the signs and symptoms of: Moderate to severe rheumatoid …

HYRIMOZ (adalimumab-adaz) is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF). HYRIMOZ is an antibody with human derived heavy and light chain …

Adalimumab-adaz is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with …

See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to …

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin …